Whan In Pharm Co.,Ltd. (KRX:016580)
11,350
0.00 (0.00%)
At close: Apr 17, 2025, 3:30 PM KST
Whan In Pharm Revenue
In the year 2024, Whan In Pharm had annual revenue of 259.60B KRW with 12.68% growth. Whan In Pharm had revenue of 66.25B in the quarter ending December 31, 2024, with 13.47% growth.
Revenue
259.60B
Revenue Growth
+12.68%
P/S Ratio
0.67
Revenue / Employee
446.04M
Employees
582
Market Cap
174.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 259.60B | 29.20B | 12.68% |
Dec 31, 2023 | 230.39B | 31.46B | 15.81% |
Dec 31, 2022 | 198.93B | 21.16B | 11.90% |
Dec 31, 2021 | 177.78B | 6.07B | 3.54% |
Dec 31, 2020 | 171.71B | 12.53B | 7.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
PharmaResearch | 350.12B |